Ari Robicsek
Impact in
- Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria
- Endocrinology top 0.2%
- Enterobacteriaceae and Cronobacter Research
- Escherichia coli research studies
Papers in
-
- Antimicrobial Resistance in Staphylococcus 21
- Clostridium difficile and Clostridium perfringens research 10
- SARS-CoV-2 and COVID-19 Research 7
- Epidemiology 17
- Pneumonia and Respiratory Infections 4
- Co-authors
- David C. Hooper (9 shared papers)George A. Jacoby (8 shared papers)Jacob Strahilevitz (9 shared papers)Lance R. Peterson (31 shared papers)Chi Hye Park (3 shared papers)Richard B. Thomson (12 shared papers)Donna M. Hacek (10 shared papers)Daniel F. Sahm (1 shared paper)
- Journals
- Infection Control and Hospital Epidemiology (11 papers)Antimicrobial Agents and Chemotherapy (10 papers)American Journal of Infection Control (8 papers)Open Forum Infectious Diseases (8 papers)Clinical Infectious Diseases (5 papers)
- Partner nations
- United StatesCanadaIsrael
In The Last Decade
Ari Robicsek
92 papers receiving 7.0k citations
Ari Robicsek's Hit Papers
Peers
Comparison fields: 5 of 150
- Molecular Medicine 3.5k
- Endocrinology 1.4k
- Applied Microbiology and Biotechnology 359
- Pollution 1.1k
- Clinical Biochemistry 618
Countries citing papers authored by Ari Robicsek
This map shows the geographic impact of Ari Robicsek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ari Robicsek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ari Robicsek more than expected).
Fields of papers citing papers by Ari Robicsek
This network shows the impact of papers produced by Ari Robicsek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ari Robicsek. The network helps show where Ari Robicsek may publish in the future.
Co-authors
The 25 scholars most cited alongside Ari Robicsek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase Hit paper breakdown → | 2005 | 762 |
| 2 | Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat Hit paper breakdown → | 2009 | 738 |
| 3 | The worldwide emergence of plasmid-mediated quinolone resistance Hit paper breakdown → | 2006 | 708 |
| 4 | Prevalence in the United States of aac(6 ′ ) - Ib - cr Encoding a Ciprofloxacin-Modifying Enzyme Hit paper breakdown → | 2006 | 636 |
| 5 | 2006 | 483 | |
| 6 | 2006 | 329 | |
| 7 | 2008 | 309 | |
| 8 | Myocarditis and Pericarditis After Vaccination for COVID-19 Hit paper breakdown → | 2021 | 267 |
| 9 | 2006 | 195 | |
| 10 | 2014 | 193 | |
| 11 | 2007 | 165 | |
| 12 | 2006 | 148 | |
| 13 | 2007 | 98 | |
| 14 | 2013 | 97 | |
| 15 | Diffusion-weighted imaging of fungal cerebral infection. | 2005 | 95 |
| 16 | 2012 | 94 | |
| 17 | 2009 | 87 | |
| 18 | 2005 | 81 | |
| 19 | 2012 | 79 | |
| 20 | 2009 | 79 |
About Ari Robicsek
Ari Robicsek is a scholar working on Infectious Diseases, Epidemiology, Molecular Medicine, Clinical Biochemistry and Pharmacology, having authored 93 papers that have together received 7.2k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (21 papers), Antibiotic Resistance in Bacteria (17 papers), Clostridium difficile and Clostridium perfringens research (10 papers), Bacterial Identification and Susceptibility Testing (9 papers), SARS-CoV-2 and COVID-19 Research (7 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Antibiotic Use and Resistance (5 papers) and Pneumonia and Respiratory Infections (4 papers). The work is most often cited by research in Molecular Medicine (3.5k citations), Endocrinology (1.4k citations), Applied Microbiology and Biotechnology (359 citations), Pollution (1.1k citations) and Clinical Biochemistry (618 citations). Ari Robicsek has collaborated with scholars based in United States, Canada and Israel. Frequent co-authors include David C. Hooper, George A. Jacoby, Jacob Strahilevitz, Lance R. Peterson, Chi Hye Park, Richard B. Thomson, Donna M. Hacek, Daniel F. Sahm, Jennifer L. Beaumont and D.F. Sahm. Their work appears in journals such as Infection Control and Hospital Epidemiology, Antimicrobial Agents and Chemotherapy, American Journal of Infection Control, Open Forum Infectious Diseases and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.